[NP_P11] Poster Session 11

[NP-P11-4] Safety and Tolerability of Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled 6-week Study (ELEVATE study)

^○Teruhiko HIGUCHI^{1, 2}, Jun ISHIGOOKA³, Mari MIYAJIMA⁴, Kei WATABE⁵, Takahiro MASUDA⁶, Tadafumi KATO⁷ (1. Japan Depression Center, Japan, 2. The National Center of Neurology and Psychiatry, Japan, 3. Institute of CNS Pharmacology, Japan, 4. Clinical Research, Sumitomo Dainippon Pharma Co., Ltd., Japan, 5. Data Science, Sumitomo Dainippon Pharma Co., Ltd., Japan, 6. Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Japan, 7. Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Japan)